BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37923359)

  • 1. Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells.
    Duranti C; Iorio J; Bagni G; Chioccioli Altadonna G; Fillion T; Lulli M; D'Alessandro FN; Montalbano A; Lastraioli E; Fanelli D; Coppola S; Schmidt T; Piazza F; Becchetti A; Arcangeli A
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37923359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.
    Becchetti A; Crescioli S; Zanieri F; Petroni G; Mercatelli R; Coppola S; Gasparoli L; D'Amico M; Pillozzi S; Crociani O; Stefanini M; Fiore A; Carraresi L; Morello V; Manoli S; Brizzi MF; Ricci D; Rinaldi M; Masi A; Schmidt T; Quercioli F; Defilippi P; Arcangeli A
    Sci Signal; 2017 Apr; 10(473):. PubMed ID: 28377405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interaction between integrins and hERG1 channels in cancer cells.
    Pillozzi S; Arcangeli A
    Adv Exp Med Biol; 2010; 674():55-67. PubMed ID: 20549940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling.
    Cherubini A; Hofmann G; Pillozzi S; Guasti L; Crociani O; Cilia E; Di Stefano P; Degani S; Balzi M; Olivotto M; Wanke E; Becchetti A; Defilippi P; Wymore R; Arcangeli A
    Mol Biol Cell; 2005 Jun; 16(6):2972-83. PubMed ID: 15800067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers.
    Duranti C; Iorio J; Lottini T; Lastraioli E; Crescioli S; Bagni G; Lulli M; Capitani C; Bouazzi R; Stefanini M; Carraresi L; Iamele L; De Jonge H; Arcangeli A
    Mol Cancer Ther; 2021 Aug; 20(8):1338-1349. PubMed ID: 34045227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.
    Crociani O; Zanieri F; Pillozzi S; Lastraioli E; Stefanini M; Fiore A; Fortunato A; D'Amico M; Masselli M; De Lorenzo E; Gasparoli L; Chiu M; Bussolati O; Becchetti A; Arcangeli A
    Sci Rep; 2013 Nov; 3():3308. PubMed ID: 24270902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.
    Pillozzi S; Brizzi MF; Bernabei PA; Bartolozzi B; Caporale R; Basile V; Boddi V; Pegoraro L; Becchetti A; Arcangeli A
    Blood; 2007 Aug; 110(4):1238-50. PubMed ID: 17420287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the hERG1 and β1 integrin complex for cancer treatment.
    Arcangeli A; Iorio J; Duranti C
    Expert Opin Ther Targets; 2024 Mar; 28(3):145-157. PubMed ID: 38372580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models.
    Chioccioli Altadonna G; Montalbano A; Iorio J; Becchetti A; Arcangeli A; Duranti C
    Membranes (Basel); 2022 Nov; 12(11):. PubMed ID: 36422154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Pillozzi S; Masselli M; De Lorenzo E; Accordi B; Cilia E; Crociani O; Amedei A; Veltroni M; D'Amico M; Basso G; Becchetti A; Campana D; Arcangeli A
    Blood; 2011 Jan; 117(3):902-14. PubMed ID: 21048156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of potassium channels in tumours of the gastrointestinal tract: a focus on the human ether-à-go-go related gene 1 channels.
    Arcangeli A; Duranti C; Iorio J; Lastraioli E
    J Physiol; 2023 May; 601(9):1597-1610. PubMed ID: 36215066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas.
    Iorio J; Antonuzzo L; Scarpi E; D'Amico M; Duranti C; Messerini L; Sparano C; Caputo D; Lavacchi D; Borzomati D; Antonelli A; Nibid L; Perrone G; Coppola A; Coppola R; di Costanzo F; Lastraioli E; Arcangeli A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interaction between integrins and hERG potassium channels.
    Arcangeli A; Becchetti A; Cherubini A; Crociani O; Defilippi P; Guasti L; Hofmann G; Pillozzi S; Olivotto M; Wanke E
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):826-7. PubMed ID: 15494025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
    Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
    Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
    Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
    Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications.
    Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Masi A; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A
    Clin Cancer Res; 2014 Mar; 20(6):1502-12. PubMed ID: 24449824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex.
    Santini L; Duranti C; Palandri C; Giammarino L; Musumeci M; Carlucci L; Capitani C; Colasurdo R; Recchia F; Cerbai E; Coppini R; Arcangeli A
    Front Pharmacol; 2023; 14():1237431. PubMed ID: 37767396
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.
    Fornaro M; Steger CA; Bennett AM; Wu JJ; Languino LR
    Mol Biol Cell; 2000 Jul; 11(7):2235-49. PubMed ID: 10888665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.
    Tringali C; Lupo B; Silvestri I; Papini N; Anastasia L; Tettamanti G; Venerando B
    J Biol Chem; 2012 Dec; 287(51):42835-45. PubMed ID: 23139422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.